Resistance to PD-1 blockade was demonstrated to originate from a complex interplay between the immune cells (CD8+ T cells, T regs, Myeloid-derived suppressor cells, Tumor-associated macrophages...) and the cancer cells within the tumor microenvironment (TME) (3–5). Here, CD8A is linked to neoplasm.